Patheon Announces Completion of Offering of $280 Million of Senior Secured Notes and Concurrent Amendment of Asset Based Loan Revolver

TORONTO, April 26 /PRNewswire-FirstCall/ - Patheon Inc. a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today the completion of its previously announced private placement of $280 million in aggregate principal amount of 8.625% senior secured notes due 2017 (the “Offering”).